These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20034558

  • 1. In vivo detection of inducible nitric oxide synthase in rodent gliomas.
    Towner RA, Smith N, Doblas S, Garteiser P, Watanabe Y, He T, Saunders D, Herlea O, Silasi-Mansat R, Lupu F.
    Free Radic Biol Med; 2010 Mar 01; 48(5):691-703. PubMed ID: 20034558
    [Abstract] [Full Text] [Related]

  • 2. Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.
    Towner RA, Smith N, Saunders D, De Souza PC, Henry L, Lupu F, Silasi-Mansat R, Ehrenshaft M, Mason RP, Gomez-Mejiba SE, Ramirez DC.
    Biochim Biophys Acta; 2013 Dec 01; 1832(12):2153-61. PubMed ID: 23959048
    [Abstract] [Full Text] [Related]

  • 3. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
    Yang T, Witham TF, Villa L, Erff M, Attanucci J, Watkins S, Kondziolka D, Okada H, Pollack IF, Chambers WH.
    Cancer Res; 2002 May 01; 62(9):2583-91. PubMed ID: 11980653
    [Abstract] [Full Text] [Related]

  • 4. In vivo detection of c-Met expression in a rat C6 glioma model.
    Towner RA, Smith N, Doblas S, Tesiram Y, Garteiser P, Saunders D, Cranford R, Silasi-Mansat R, Herlea O, Ivanciu L, Wu D, Lupu F.
    J Cell Mol Med; 2008 May 01; 12(1):174-86. PubMed ID: 18194445
    [Abstract] [Full Text] [Related]

  • 5. Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.
    He T, Smith N, Saunders D, Pittman BP, Lerner M, Lightfoot S, Silasi-Mansat R, Lupu F, Towner RA.
    Am J Nucl Med Mol Imaging; 2013 May 01; 3(4):300-11. PubMed ID: 23901356
    [Abstract] [Full Text] [Related]

  • 6. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH, Yang DI, Chou H, Thompson EM, Xu J, Hsu CY.
    J Pharmacol Exp Ther; 2001 Apr 01; 297(1):308-15. PubMed ID: 11259558
    [Abstract] [Full Text] [Related]

  • 7. Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model.
    Yamaguchi S, Bell HS, Shinoda J, Holmes MC, Wharton SB, Whittle IR.
    Br J Neurosurg; 2002 Dec 01; 16(6):567-72. PubMed ID: 12617238
    [Abstract] [Full Text] [Related]

  • 8. "Facilitated" amino acid transport is upregulated in brain tumors.
    Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R.
    J Cereb Blood Flow Metab; 1998 May 01; 18(5):500-9. PubMed ID: 9591842
    [Abstract] [Full Text] [Related]

  • 9. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
    Isakovic A, Harhaji L, Dacevic M, Trajkovic V.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):106-13. PubMed ID: 18606162
    [Abstract] [Full Text] [Related]

  • 10. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan 04; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of eNOS in vascular permeability in ENU-induced gliomas.
    Bulnes S, Argandoña EG, Bengoetxea H, Leis O, Ortuzar N, Lafuente JV.
    Acta Neurochir Suppl; 2010 Jan 04; 106():277-82. PubMed ID: 19812964
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells.
    Shinoda J, McLaughlin KE, Bell HS, Swaroop GR, Yamaguchi S, Holmes MC, Whittle IR.
    Glia; 2003 Apr 01; 42(1):68-76. PubMed ID: 12594738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
    Vince GH, Bendszus M, Schweitzer T, Goldbrunner RH, Hildebrandt S, Tilgner J, Klein R, Solymosi L, Christian Tonn J, Roosen K.
    Exp Neurol; 2004 Dec 01; 190(2):478-85. PubMed ID: 15530886
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.